Q&A Session at 2022 Annual General Meeting

Imagion Biosystems recording of the Q&A session at the 2022 Annual General Meeting. Imagion Biosystems' board of directors answer questions from…


Presentation Visuals from 25th May 2022 Annual General Meeting

The presentation visuals from the 25th May 2022 Annual General Meeting are now available. You can find the 2022 AGM Investor Presentation here.    …


Health Industry Hub Interview

Bob Proulx sat down with Rozalina Sarkezians, Managing Director & Founder of Health Industry Hub, for a chat about Imagion Biosystem’s work developing our…


Ticker News Interview - Breast Cancer Clinical Trial Update

Bob Proulx discusses updates on the first-in-human MagSense® HER2 breast cancer clinical trial with TickerTV - trial is progressing positively.  …


Imagion Bio at The Edison Open House: Global Healthcare 2022

Our CEO, Bob Proulx, connected with the Edison Group during their Global Healthcare Open House to discuss in detail, the nanotechnology behind our bio-imaging…


Magnetic Nanoparticles as Imaging Agents Presentation at the 2021 VBIC Meeting

As a sponsor of the 2021 Annual VBIC Network Meeting, Imagion Biosystems' President and CEO, Bob Proulx, gave a presentation on magnetic nanoparticles as…


Q&A with Chief Development Officer Yalia Jayalakshmi, Ph.D.

In this video, Chief Development Officer Yalia Jayalakshmi, Ph.D. explains why she joined Imagion Biosystems, the urgency of the company's mission, and the…


New Imaging Technology for Early Detection

Early detection is critical to improving cancer survival rates. Too often, the limitations of today's medical imaging technologies result in cancer being…


First in-human study update - webcast presentation

You can also register to watch the entire Zoom webcast on-demand by clicking here


Bob Proulx Discusses the Opportunity for MagSense® Imaging

Watch Imagion CEO Bob Proulx discuss the opportunity for MagSense® Imaging on Switzer's CEO Masterclass: https://youtu.be/kpJ0Lpwdk38 Today’s imaging…